A team of researchers affiliated with multiple institutions in the U.K. and Australia has developed a nontraditional ointment to treat skin wound infections based on a molecule found in the sap of a Queensland blushwood tree. ...
A single research test has the potential to predict which patients treated with immunotherapies—which harness the immune system to attack cancer cells—are likely to have their cancer recur or have severe side effects, ...
Sep 15, 2022
0
54
Every day we inhale thousands of potentially pathogenic fungal spores, but our immune system simply eliminates them. However, in people with compromised immunity, such as transplant and cancer patients, as well as hospitalized ...
Sep 12, 2022
0
148
Blood tests—simple, noninvasive and economically feasible—promise to become the next major milestone in cancer diagnosis. However, most of these tests, dubbed liquid biopsies, are currently not reliable enough for widespread ...
Sep 8, 2022
0
81
The U.S. Food and Drug Administration has approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood ...
Aug 23, 2022
0
7
Rice University and Baylor College of Medicine researchers have shown they can eradicate advanced-stage mesothelioma tumors in mice in just a few days with a treatment combining Rice's cytokine "drug factory" implants and ...
Aug 22, 2022
0
177
A new study has found that a current cancer diagnosis posed a significant risk for severe outcomes during the first two years of the COVID-19 pandemic, including ICU admission and death. UC Davis Comprehensive Cancer Center ...
Aug 17, 2022
0
84
Researchers at the Georgia Institute of Technology have found a detection method that could revolutionize cancer treatment by showing how cancers metastasize and what stage they are.
Aug 12, 2022
0
87
A new study in the August 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network suggests a new way for hematologic oncologists to protect older patients from the risks of medication interactions.
Aug 10, 2022
0
39
Results of an international clinical trial co-led by researchers at Winship Cancer Institute at Emory University show potential for a novel drug to benefit patients with multiple myeloma whose disease either recurred or was ...
Aug 3, 2022
0
1509
